Innovent Biologics Inc. (IVBXF)
PNK: IVBXF
· Real-Time Price · USD
5.97
0.00 (0.00%)
At close: Apr 29, 2025, 8:00 PM
0.00% (1D)
| Bid | 5.97 |
| Market Cap | 9.79B |
| Revenue (ttm) | 7.46B |
| Net Income (ttm) | -1.28B |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | -597.5 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.39 |
| Volume | 100 |
| Avg. Volume (20D) | 5,323 |
| Open | 5.49 |
| Previous Close | 5.97 |
| Day's Range | 5.49 - 5.97 |
| 52-Week Range | 3.91 - 6.40 |
| Beta | 0.30 |
About IVBXF
Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma. The company also offers Byvas...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 4, 2019
Employees 5,659
Stock Exchange PNK
Ticker Symbol IVBXF
Website https://www.innoventbio.com